Diagnosis of multiple sclerosis; especially useful in patients with equivocal clinical presentation and radiological findings
Determining number of serum oligoclonal bands in order to calculate the number of cerebrospinal fluid-specific bands present
Only orderable as part of a profile. For more information see:
-OLIG / Oligoclonal Banding, Serum and Spinal Fluid
-MSP3 / Multiple Sclerosis (MS) Cascade, Serum and Spinal Fluid
Isoelectric Focusing (IEF) with IgG Immunoblot Detection
Oligoclonal Banding ORDER OLIG
Multiple sclerosis (MS)
Serum
Only orderable as part of a profile. For more information see:
-OLIG / Oligoclonal Banding, Serum and Spinal Fluid
-MSP3 / Multiple Sclerosis (MS) Cascade, Serum and Spinal Fluid
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Within 2 hours of collection, centrifuge and aliquot serum into a plastic vial.
2. Label specimen as serum.
0.4 mL
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Ambient | 14 days | |
Refrigerated (preferred) | 14 days | ||
Frozen | 14 days |
Diagnosis of multiple sclerosis; especially useful in patients with equivocal clinical presentation and radiological findings
Determining number of serum oligoclonal bands in order to calculate the number of cerebrospinal fluid-specific bands present
The diagnosis of multiple sclerosis (MS) is dependent on clinical, radiological, and laboratory findings. The detection of increased intrathecal immunoglobulin (Ig) synthesis is the basis for current diagnostic laboratory tests for MS. These tests include kappa free light chains in the cerebrospinal fluid (CSF) and CSF oligoclonal band (OCB) detection. Abnormal CSF OCB patterns have been reported in 70% to 80% of MS patients.
Increased intrathecal Ig synthesis may occur in other inflammatory CSF diseases, and therefore, this assay is not specific for MS
Only orderable as part of a profile. For more information see:
-OLIG / Oligoclonal Banding, Serum and Spinal Fluid
-MSP3 / Multiple Sclerosis (MS) Cascade, Serum and Spinal Fluid
CSF Oligoclonal Bands Interpretation: <2 bands
When the oligoclonal band assay detects 2 or more unique IgG bands in the cerebrospinal fluid (CSF), the result is positive.
Cerebrospinal fluid is used in the diagnosis of multiple sclerosis (MS) by identifying increased intrathecal IgG synthesis qualitatively (oligoclonal bands). The presence of 2 or more unique CSF oligoclonal bands was reintroduced as one of the diagnostic criteria for MS in the 2017 revised McDonald criteria. These findings, however, are not specific for MS as CSF-specific IgG synthesis may also be found in patients with other neurologic diseases including infectious, inflammatory, cerebrovascular, and paraneoplastic disorders. Clinical correlation recommended.
These tests are not specific for multiple sclerosis.
1. Andersson M, Alvarez-Cermeno J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994;57(8):897-902
2. Fortini AS, Sanders EL, Weinshenker BG, Katzmann JA. Cerebrospinal fluid oligoclonal bands in the diagnosis of multiple sclerosis. Isoelectric focusing with IgG immunoblotting compared with high-resolution agarose gel electrophoresis and cerebrospinal fluid IgG index. Am J Clin Pathol. 2003;120(5):672-675
3. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173
4. Gurtner KM, Shosha E, Bryant SC, et al. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes. Clin Chem Lab Med. 2018;56(7):1071-1080
5. Saadeh R, Pittock S, Bryant S, et al. CSF kappa free light chains as a potential quantitative alternative to oligoclonal bands in multiple sclerosis. Neurology. 2019;92(15_supplement). doi:10.1212/WNL.92.15_supplement.S37.001
The oligoclonal band (OCB) assay requires paired cerebrospinal fluid (CSF) and serum samples. Unconcentrated CSF and diluted serum are electrophoresed by isoelectric focusing. The separated immunoglobulins (Ig) are visualized by an IgG immunoblot, and OCBs that are present in the CSF and not in the serum are reported. The assay uses reagents from Helena Laboratories.(Package insert: SPIFE Touch IgG IEF Procedure. Helena Laboratories; 02/2024)
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.
83916
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
OLIGS | Serum Bands | 100755-8 |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
2783 | Serum Bands | 100755-8 |